Corrigendum: Impact of duration of critical illness on the arenal glands of human intensive care patients (Journal of Clinical Endocrinology and Metabolism (2014) 99:11 (4214-4222) DOI: 10.1210/jc.2014-2429);Impact of duration of critical illness on the adrenal glands of human intensive care patients

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages 4214-4222

  Boonen, Eva ^a   Langouche, Lies ^a   Janssens, Thomas ^a   Meersseman, Philippe ^b   Vervenne, Hilke ^a   De Samblanx, Emilie ^a   Pironet, Zoë ^a   Van Dijck, Lisa ^a   Vander Perre, Sarah ^a   Derese, Inge ^a   Van Den Berghe, Greet ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CORTICOTROPIN; EOSIN; HEMATOXYLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MELANOCORTIN 2 RECEPTOR; MESSENGER RNA; PROTEIN; SCAVENGER RECEPTOR B; STEROIDOGENIC ACUTE REGULATORY PROTEIN; HMGCR PROTEIN, HUMAN; PHOSPHOPROTEIN; SCARB1 PROTEIN, HUMAN;

ADRENAL CORTEX; ADRENAL GLAND; ADRENAL INSUFFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; MALE; MICROSCOPY; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; STAINING; ADULT; AGED; GENETICS; INTENSIVE CARE; LENGTH OF STAY; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADRENAL GLANDS; ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL ESTERS; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CRITICAL ILLNESS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PHOSPHOPROTEINS; RECEPTOR, MELANOCORTIN, TYPE 2; SCAVENGER RECEPTORS, CLASS B; YOUNG ADULT;

EID: 84909992139     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00608     Document Type: Erratum

References (29)

1. Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N Engl J Med. 2013; 368: 1477-1488.
2. Bornstein SR, Chrousos GP. Clinical review 104: adrenocorticotropin (ACTH)-and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999; 84: 1729-1736.
3. Coll AP, Challis BG, Yeo GS, et al. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology. 2004; 145: 4721-4727.
4. Simpson ER, Waterman MR. Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex. Can J Biochem Cell Biol 1983; 61: 692-707.
5. Liu J, Heikkila P, Meng QH, Kahri AI, Tikkanen MJ, Voutilainen R. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol. 2000; 142: 677-682.
6. Kraemer FB, Shen WJ. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res 2002; 43: 1585-1594.
7. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996; 17: 221-244.
8. Stocco DM, Clark BJ. The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids. 1997; 62: 29-36.
9. Lehoux JG, Lefebvre A, Belisle S, Bellabarba D. Hormonal regulation of 3-hydroxy-3-methylglutaryl coenzymeAreductasemRNAin the rat adrenal gland. J Steroid Biochem. 1989; 34: 379-384.
10. Lehoux JG, Fleury A, Ducharme L. The acute and chronic effects of adrenocorticotropin on the levels of messenger ribonucleic acid and protein of steroidogenic enzymes in rat adrenal in vivo. Endocrinology. 1998; 139: 3913-3922.
11. Lebrethon MC, Naville D, Begeot M, Saez JM. Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest. 1994; 93: 1828-1833.
12. Karpac J, Czyzewska K, Kern A, Brush RS, Anderson RE, Hochgeschwender U. Failure of adrenal corticosterone production in POMC-deficient mice results from lack of integrated effects ofPOMC peptides on multiple factors. Am J Physiol Endocrinol Metab. 2008; 295: E446-E455.
13. Krude H, Gruters A. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab. 2000; 11: 15-22.
14. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma. 1997; 42: 27-31.
15. Bollen TL, van Santvoort HC, Besselink MG, van Ramshorst B, van Es HW, Gooszen HG. Dutch Acute Pancreatitis Study Group. Intense adrenal enhancement in patients with acute pancreatitis and early organ failure. Emerg Radiol. 2007; 14: 317-322.
16. Polito A, Mansart A, Louiset E, et al. Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals. Intensive Care Med. 2010; 36: 1852-1858.
17. Ferreira JG, Cruz CD, Neves D, Pignatelli D. Increased extracellular signal regulated kinases phosphorylation in the adrenal gland in response to chronicACTHtreatment. J Endocrinol. 2007; 192: 647-658.
18. Michalaki M, Margeli T, Tsekouras A, Gogos CH, Vagenakis AG, Kyriazopoulou V. Hypothalamic-pituitary-adrenal axis response to the severity of illness in non-critically ill patients: does relative corticosteroid insufficiency exist? Eur J Endocrinol. 2010; 162: 341-347.
19. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. 1995; 80: 1238-1242.
20. Boonen E, Meersseman P, Vervenne H, et al. Reduced nocturnal ACTH-driven cortisol secretion during critical illness. Am J Physiol Endocrinol Metab 2014; 306(8): E883-E892.
21. Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 2005; 34: 371-384, ix.
22. Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev. 2001; 22: 75-110.
23. Spiga F, Waite EJ, Liu Y, Kershaw YM, Aguilera G, Lightman SL. ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology. 2011; 152: 1448-1457.
24. O'Donnell WM, Fajans SS, Weinbaum JG. Human adrenal cortex after administration of ACTH and cortisone; morphologic changes. AMA Arch Intern Med. 1951; 88: 28-35.
25. Symington T, Duguid WP, Davidson JN. Effect of exogenous corticotropin on the histochemical pattern of the human adrenal cortex and a comparison with the changes during stress. J Clin Endocrinol Metab. 1956; 16: 580-598.
26. Hornsby PJ. Aging of the human adrenal cortex. Sci Aging Knowledge Environ 2004; 2004: re6.
27. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E A. Three-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038-1045.
28. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41: 580-637.
29. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008; 36: 1937-1949.